C. Piazza

C. Piazza

Chief Executive Officer at
IGL Pharma, Inc.
79 year
Health Technology
Consumer Services
Commercial Services

Profile

C.
Richard Piazza
was the founder of QSAM Biosciences, Inc. (founded in 2004) where he served as the Executive Chairman from 2020 to 2024.
He is currently the President & Chief Executive Officer of IGL Pharma, Inc. (since 2017) and the Chairman of NovaScan, Inc. (since 2018).
In the past, he held positions as the President & Chief Executive Officer of Maxia Pharmaceuticals, Inc. (2001-2002), VitaGen, Inc. (2002-2003), and TheraFuse, Inc. (2003-2004).
He also served as the Chief Executive Officer of SynVivo, Inc. (2014-2016) and as the Managing Director of Healthios Capital Markets LLC (2004-2007) and the Managing Partner of La Jolla Capital Partners, Inc. (2004-2007).
Additionally, he has held the title of Chairman at Chemokine Therapeutics Corp.
Dr. Piazza obtained a doctorate degree from the University of Leeds, a graduate degree from the State University of New York at Buffalo, and an undergraduate degree from The State University of New York.

C. Piazza active positions

CompaniesPositionStart
Chief Executive Officer 01/01/2017
Chairman 01/11/2018

Former positions of C. Piazza

CompaniesPositionEnd
Founder 02/05/2024
Chief Executive Officer 01/01/2016
La Jolla Capital Partners, Inc.
Corporate Officer/Principal 01/01/2007
Corporate Officer/Principal 01/01/2007
President 01/09/2004
See the detail of C. Piazza's experience

Training of C. Piazza

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

25

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Finance

La Jolla Capital Partners, Inc.

Health Technology

Process Industries

Health Services

Health Technology

Technology Services